Sep 8, 2026 07:30AM
Sep 8, 2026 07:30AM
May 14, 2026 07:30AM
May 13, 2026 07:30AM
May 13, 2026 07:30AM
May 12, 2026 07:30AM
May 12, 2026 07:30AM BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients
May 7, 2026 07:30AM
May 7, 2026 07:30AM
May 6, 2026 07:30AM
Jan 27, 2026 07:30AM
Jan 27, 2026 07:30AM
Nov 25, 2025 07:30AM
Nov 25, 2025 07:30AM BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025
Oct 22, 2025 07:30AM
Oct 22, 2025 07:30AM
Oct 21, 2025 07:50AM
Oct 21, 2025 07:50AM
Oct 20, 2025 07:31AM
Oct 20, 2025 07:30AM
Jul 31, 2025 07:30AM BriaCell adds UCLA Health to phase 3 breast cancer trial
Jul 31, 2025 07:30AM
Jul 2, 2025 07:30AM
Jun 24, 2025 07:30AM
May 23, 2025 07:42AM
May 23, 2025 07:30AM
Apr 22, 2025 07:30AM
Mar 20, 2025 08:00AM Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell’s Phase 3 Study in Metastatic Breast Cancer
Dec 2, 2024 07:50AM
Dec 2, 2024 07:50AM
Oct 15, 2024 07:51AM
Oct 15, 2024 07:50AM
Sep 10, 2024 07:51AM
Sep 10, 2024 07:50AM
Jun 27, 2023 08:05AM FDA Approves BriaCell’s Pivotal Registrational Study Design in Advanced Metastatic Breast Cancer
May 15, 2023 08:01AM
May 15, 2023 08:00AM
Feb 23, 2023 08:03AM
Feb 23, 2023 08:00AM
Jan 24, 2023 09:07AM
Jan 18, 2023 08:48AM
Jan 18, 2023 08:47AM BriaCell Announces Positive End of Phase II Meeting with the FDA for Bria-IMT™ Combination in Advanced Metastatic Breast Cancer
Jan 10, 2023 09:00AM
Dec 8, 2022 09:25AM
Nov 10, 2022 09:01AM
Nov 10, 2022 09:00AM
Oct 21, 2022 09:00AM
Jul 5, 2022 09:00AM
Jun 24, 2022 09:00AM BriaCell Anti-Cancer Technology Published in Leading Cancer Drug Discovery Journal
May 18, 2022 09:15AM

330,721 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All